173 related articles for article (PubMed ID: 2478164)
1. Resistance of vaccinia virus to interferons: modulation of the 2-5A system in interferon-treated, vaccinia virus infected cells.
Páez E; Esteban M
Microbiologia; 1987 Oct; 3(3):163-78. PubMed ID: 2478164
[TBL] [Abstract][Full Text] [Related]
2. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
Díaz-Guerra M; Rivas C; Esteban M
Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
[TBL] [Abstract][Full Text] [Related]
3. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).
Esteban M; Patiño C
J Interferon Cytokine Res; 2000 Oct; 20(10):867-77. PubMed ID: 11054274
[TBL] [Abstract][Full Text] [Related]
4. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
Rice AP; Roberts WK; Kerr IM
J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
[TBL] [Abstract][Full Text] [Related]
5. Mode of sensitivity and resistance of vaccinia virus replication to interferon.
Esteban M; Benavente J; Paez E
J Gen Virol; 1986 Apr; 67 ( Pt 4)():801-8. PubMed ID: 3958696
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.
Rivas C; Gil J; Mĕlková Z; Esteban M; Díaz-Guerra M
Virology; 1998 Apr; 243(2):406-14. PubMed ID: 9568039
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses.
Beattie E; Paoletti E; Tartaglia J
Virology; 1995 Jul; 210(2):254-63. PubMed ID: 7542414
[TBL] [Abstract][Full Text] [Related]
8. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.
Paez E; Esteban M
Virology; 1984 Apr; 134(1):12-28. PubMed ID: 6324465
[TBL] [Abstract][Full Text] [Related]
9. Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.
Paez E; Esteban M
J Virol; 1985 Oct; 56(1):75-84. PubMed ID: 3861876
[TBL] [Abstract][Full Text] [Related]
10. Effect of interferon on integrity of vaccinia virus and ribosomal RNA in infected cells.
Esteban M; Benavente J; Paez E
Virology; 1984 Apr; 134(1):40-51. PubMed ID: 6200994
[TBL] [Abstract][Full Text] [Related]
11. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells.
Díaz-Guerra M; Rivas C; Esteban M
Virology; 1997 Sep; 236(2):354-63. PubMed ID: 9325243
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon.
Whitaker-Dowling P; Youngner JS
Virology; 1986 Jul; 152(1):50-7. PubMed ID: 2424172
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
[TBL] [Abstract][Full Text] [Related]
14. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the antiviral action of interferon and prostaglandins in virus-infected murine cells.
Santoro MG; Jaffe BM; Paez E; Esteban M
Biochem Biophys Res Commun; 1983 Oct; 116(2):442-8. PubMed ID: 6197067
[TBL] [Abstract][Full Text] [Related]
16. Protein binding to the interferon response enhancer correlates with interferon induction of 2'-5'-oligoadenylate synthetase in normal and interferon-resistant Friend cells.
Coccia EM; Vaiman D; Raber J; Marziali G; Fiorucci G; Orsatti R; Cohen B; Nissim N; Romeo G; Affabris E
J Virol; 1991 Apr; 65(4):2081-7. PubMed ID: 1705997
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of interferon-sensitive cells derived from an interferon-resistant NIH 3T3 line.
Mittnacht S; Jacobsen H
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2945-51. PubMed ID: 2445907
[TBL] [Abstract][Full Text] [Related]
18. Identification of cellular genes induced in human cells after activation of the OAS/RNaseL pathway by vaccinia virus recombinants expressing these antiviral enzymes.
Domingo-Gil E; González JM; Esteban M
J Interferon Cytokine Res; 2010 Mar; 30(3):171-88. PubMed ID: 20038200
[TBL] [Abstract][Full Text] [Related]
19. The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
Meurs E; Krause D; Robert N; Silverman RH; Hovanessian AG
Prog Clin Biol Res; 1985; 202():307-15. PubMed ID: 2421309
[No Abstract] [Full Text] [Related]
20. Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2'p)nA-synthetase.
Paez E; Esteban M
Virology; 1984 Apr; 134(1):29-39. PubMed ID: 6324475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
